{
    "clinical_study": {
        "@rank": "161598", 
        "arm_group": {
            "arm_group_label": "Picosure Laser System", 
            "arm_group_type": "Experimental", 
            "description": "Picosure Laser System for the treatment of unwanted tattoos"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the Picosure Laser System for the treatment of\n      unwanted tattoos."
        }, 
        "brief_title": "Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Unwanted Tattoos", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is a healthy male or female between 18 and 85 years old.\n\n          2. Is willing to consent to participate in the study.\n\n          3. Is willing to comply with all requirements of the study including being photographed,\n             following post treatment care and attending all treatment and follow up visits.\n\n          4. The tattoo must include red pigment.\n\n        Exclusion Criteria:\n\n          1. Is female and pregnant, has been pregnant within the last 3 months, is currently\n             breast feeding or planning a pregnancy during the study period.\n\n          2. Is hypersensitive to light exposure OR takes photo sensitized medication.\n\n          3. Has active or localized systemic infections.\n\n          4. Has a coagulation disorder or is currently using anti-coagulation medication\n             (including but not limited to the heavy use of aspirin {greater than 81 mg per day}).\n\n          5. Has any condition which, in the investigator's opinion, would make it unsafe for the\n             subject to participate in this research study.\n\n          6. Is currently enrolled in an investigational drug or device trial, or has received an\n             investigational drug or been treated with an investigational device within 3 months\n             prior to entering this study.\n\n          7. Has used Accutane within 6 months prior to enrollment.\n\n          8. Has the need to be exposed to artificial tanning devices or excessive sunlight during\n             the trial.\n\n          9. Has had prior treatment with parenteral gold therapy (gold sodium thiomalate).\n\n         10. Has a history of keloids.\n\n         11. Has evidence of compromised wound healing.\n\n         12. Has a history of basal cell carcinoma, squamous cell carcinoma or melanoma.\n\n         13. Has a history of immunosuppression/immune deficiency disorders (including HIV\n             infection or AIDS) or use of immunosuppressive medications or has an autoimmune\n             disorder.\n\n         14. Is allergic to topical lidocaine or topical steroids."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02110095", 
            "org_study_id": "CYN14-PICO-MULTI-JD"
        }, 
        "intervention": {
            "arm_group_label": "Picosure Laser System", 
            "description": "Picosure Laser System for the Treatment of Unwanted Tattoos", 
            "intervention_name": "Picosure Laser System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chestnut Hill", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02467"
                }, 
                "name": "Skin Care Physicians"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Tattoo clearance will be measured using baseline and 2 month post treatment photos using a photographic scale", 
            "measure": "Tattoo Clearance", 
            "safety_issue": "No", 
            "time_frame": "2 months post last treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02110095"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Satisfaction Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "2 months post last treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}